相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and Feasibility of Repeated and Transient Blood-Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma
Ahmed Idbaih et al.
CLINICAL CANCER RESEARCH (2019)
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response
Emma Haapaniemi et al.
NATURE MEDICINE (2018)
Acute kidney injury after high dose etoposide phosphate: A retrospective study in children receiving an allogeneic hematopoetic stem cell transplantation
Delphine Barnoud et al.
PEDIATRIC BLOOD & CANCER (2018)
Revealing nascent proteomics in signaling pathways and cell differentiation
Craig M. Forester et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens
Cheng-Han Tsai et al.
Oncotarget (2018)
Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy
Amol Mehta et al.
FRONTIERS IN NEUROLOGY (2018)
Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis
Christoph Krisp et al.
BRITISH JOURNAL OF CANCER (2018)
Metabolomic profiling of human lung tumor tissues - nucleotide metabolism as a candidate for therapeutic interventions and biomarkers
Paula Moreno et al.
MOLECULAR ONCOLOGY (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
CRISPR-UMI : single-cell lineage tracing of pooled CRISPR-Cas9 screens
Georg Michlits et al.
NATURE METHODS (2017)
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
Julia Joung et al.
NATURE PROTOCOLS (2017)
Inhibition of post-transcriptional steps in ribosome biogenesis confers cytoprotection against chemotherapeutic agents in a p53-dependent manner
Russell T. Sapio et al.
SCIENTIFIC REPORTS (2017)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
The Fanconi anaemia pathway: newyplayers and new functions
Raphael Ceccaldi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
Carl Koschmann et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Topoisomerase II beta interacts with cohesin and CTCF at topological domain borders
Liis Uuskula-Reimand et al.
GENOME BIOLOGY (2016)
Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer
Ruud H. Wijdeven et al.
CANCER RESEARCH (2015)
Cell cycle regulation of human DNA repair and chromatin remodeling genes
Robin Mjelle et al.
DNA REPAIR (2015)
Pharmacogenomic agreement between two cancer cell line data sets
Nicolas Stransky et al.
NATURE (2015)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma
Adam M. Sonabend et al.
NEURO-ONCOLOGY (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Genetic Screens in Human Cells Using the CRISPR-Cas9 System
Tim Wang et al.
SCIENCE (2014)
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Dominik Sturm et al.
CANCER CELL (2012)
Tissue concentration of systemically administered antineoplastic agents in human brain tumors
Marshall W. Pitz et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
D. A. Reardon et al.
BRITISH JOURNAL OF CANCER (2009)
DNA topoisomerase II and its growing repertoire of biological functions
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
GSEA-P:: A desktop application for Gene Set Enrichment Analysis
Aravind Subramanian et al.
BIOINFORMATICS (2007)
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults
Santosh Kesari et al.
NEURO-ONCOLOGY (2007)
Cell apoptosis: Requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3
Chengrong Lu et al.
MOLECULAR CELL (2006)
The apoptosome activates caspase-9 by dimerization
C Pop et al.
MOLECULAR CELL (2006)
A role for proapoptotic BID in the DNA-damage response
SS Zinkel et al.
CELL (2005)
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
E Franceschi et al.
BRITISH JOURNAL OF CANCER (2004)
分享论文
